Trial Condition(s):

Hepatocellular carcinoma, Treatment of advanced renal cell carcinoma

BAY43-9006/sorafenib+gem+cisplatin Phase I combination study

Bayer Identifier:

12386

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2006-003530-14

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
20
Trial Dates
black-arrow
Phase
1
Could I receive a placebo?
No
Products
Nexavar (Sorafenib, BAY43-9006)
Accepts Healthy Volunteers
N/A

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Marienhospital Herne Universitätsklinik

Herne, Germany, 44625

Status
Completed
 

For details, please refer to trial results

Additional Information